Products affected by action to stop imports from Micro Labs in India
Health Canada took action on October 27, 2014 to stop the import of health products from the following sites in India: Micro Labs - Bangalore, Goa and Tamil Nadu/Hosur.
These lists are based on the most recent information received by Health Canada as of October 27, 2014. The lists will continue to be updated as new information becomes available.
Medically Necessary Products
Medically Necessary Products
To date no products manufactured at these sites for the Canadian market have been determined to be medically necessary. Products will continue to be assessed for medical necessity and the list will be updated should new information become available.
Company name | Products |
---|---|
Actavis | ACT Tramadol/ACET |
ECL Pharma Group Ltd. | ECL Metformin |
Jamp Pharma Corporation | JAMP Metformin |
JAMP Simvastatin | |
Marcan Pharmaceuticals Inc. | MAR Fluoxetine |
MAR Metformin | |
MAR Simvastatin | |
Mylan Pharmaceuticals ULC | MYLAN Doxazosin |
MYLAN Terbinafine | |
Pharmascience Inc. | PMS-Diclofenac/Misoprostol |
Ranbaxy Pharmaceuticals Canada Inc. | RAN Metformin |
Septa Pharmaceuticals Inc. | SEPTA Metformin |
Vita Health | Arthritis Pain Relief |
Page details
- Date modified: